BRAF and melanoma: SIRT1 inhibition by sirtinol or EX-527 re-sensitized resistant BRAF-mutant melanoma cells to vemurafenib, and it was shown that SIRT1 downregulation promotes senescence, while upregulation promotes proliferation[130].